# Evaluation of Oral Lipid Ingestion in Relation to Ovarian Androgen Secretion in Polycystic Ovary Syndrome (PCOS)

> **NCT01489319** · PHASE1 · TERMINATED · sponsor: **Indiana University** · enrollment: 47 (actual)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** Salsalate
- **DRUG:** Salsalate

## Key facts

- **NCT ID:** NCT01489319
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-02
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 47 (ACTUAL)
- **Why stopped:** The PI left Indiana University. The findings served as preliminary data for a recently awarded NIH R01 grant.
- **Last updated:** 2017-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01489319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01489319, "Evaluation of Oral Lipid Ingestion in Relation to Ovarian Androgen Secretion in Polycystic Ovary Syndrome (PCOS)". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT01489319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*